InWith Corp. to Build 'InLens 1.0' Mobile Contact Lenses Using Patented EPGL Technology
News provided by
EP Global Communications, Inc.
Jan 10, 2017, 14:57 ET
IRVINE, Calif., Jan. 10, 2017 /PRNewswire/ -- EP Global Communications, Inc. (Public OTC: EPGL)
EPGL and InWith Corp. announced today that they will partner to build the "InLens 1.0" brand of electronic augmented, mobile contact lenses. The "InLens" line is planned to include augmented reality, autofocus and more electronic contact lens applications tied to mobile phone applications. In 2016, EPGL received the US Patent on the "Elastic Circuit" which is an essential element for molding and mass production of soft electronic contact lenses. Electronically enhanced contact lenses are the ultimate platform for augmented vision ($150 billion estimated market), advanced forms of vision correction, diagnostics and drug delivery. "InLenses" will be built to be compatible with both Apple iOS and Google Android Operating systems. The mobile network will open the door to perhaps hundreds of vision based display applications in the future. EPGL has multiple ophthalmic patents pending in this field.
Already, Johnson & Johnson Vision Care, Inc. has acquired first rights to purchase the working products that are built from EPGL technologies. Today's announcement marks the beginning of the next phase for building and commercialization.
"With our progress, we have the unprecedented opportunity to become the market leader in this multi-billion dollar electronic /ophthalmic field. We now own the IP that giants have been seeking and we have the know-how to back up what we have planned," said Michael Hayes, President of EPGL.
For more information about InWith Corporation, visit www.inwithcorp.com
About EP Global Communications, Inc.
EP Global Communications, Inc. is an advanced technology research and development company for both medical devices and consumer electronics devices specializing in microelectronic mechanical systems (MEMS).
For more information about EP Global Communications, Inc., visit www.epglmed.com
Safe Harbor Statement
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
SOURCE EP Global Communications, Inc.
https://twitter.com/InwithCorp
News provided by
EP Global Communications, Inc.
Jan 10, 2017, 14:57 ET
IRVINE, Calif., Jan. 10, 2017 /PRNewswire/ -- EP Global Communications, Inc. (Public OTC: EPGL)
EPGL and InWith Corp. announced today that they will partner to build the "InLens 1.0" brand of electronic augmented, mobile contact lenses. The "InLens" line is planned to include augmented reality, autofocus and more electronic contact lens applications tied to mobile phone applications. In 2016, EPGL received the US Patent on the "Elastic Circuit" which is an essential element for molding and mass production of soft electronic contact lenses. Electronically enhanced contact lenses are the ultimate platform for augmented vision ($150 billion estimated market), advanced forms of vision correction, diagnostics and drug delivery. "InLenses" will be built to be compatible with both Apple iOS and Google Android Operating systems. The mobile network will open the door to perhaps hundreds of vision based display applications in the future. EPGL has multiple ophthalmic patents pending in this field.
Already, Johnson & Johnson Vision Care, Inc. has acquired first rights to purchase the working products that are built from EPGL technologies. Today's announcement marks the beginning of the next phase for building and commercialization.
"With our progress, we have the unprecedented opportunity to become the market leader in this multi-billion dollar electronic /ophthalmic field. We now own the IP that giants have been seeking and we have the know-how to back up what we have planned," said Michael Hayes, President of EPGL.
For more information about InWith Corporation, visit www.inwithcorp.com
About EP Global Communications, Inc.
EP Global Communications, Inc. is an advanced technology research and development company for both medical devices and consumer electronics devices specializing in microelectronic mechanical systems (MEMS).
For more information about EP Global Communications, Inc., visit www.epglmed.com
Safe Harbor Statement
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
SOURCE EP Global Communications, Inc.
https://twitter.com/InwithCorp
